274 related articles for article (PubMed ID: 33089751)
21. Nitidine chloride suppresses epithelial-mesenchymal transition and stem cell-like properties in glioblastoma by regulating JAK2/STAT3 signaling.
Jia M; Wang Y; Guo Y; Yu P; Sun Y; Song Y; Zhao L
Cancer Med; 2021 May; 10(9):3113-3128. PubMed ID: 33788424
[TBL] [Abstract][Full Text] [Related]
22. Inhibitory effect of melatonin on hypoxia-induced vasculogenic mimicry via suppressing epithelial-mesenchymal transition (EMT) in breast cancer stem cells.
Maroufi NF; Amiri M; Dizaji BF; Vahedian V; Akbarzadeh M; Roshanravan N; Haiaty S; Nouri M; Rashidi MR
Eur J Pharmacol; 2020 Aug; 881():173282. PubMed ID: 32580038
[TBL] [Abstract][Full Text] [Related]
23. Dual role of WNT5A in promoting endothelial differentiation of glioma stem cells and angiogenesis of glioma derived endothelial cells.
Chen T; Zhang F; Liu J; Huang Z; Zheng Y; Deng S; Liu Y; Wang J; Sun X
Oncogene; 2021 Aug; 40(32):5081-5094. PubMed ID: 34188250
[TBL] [Abstract][Full Text] [Related]
24. Emodin reduces Breast Cancer Lung Metastasis by suppressing Macrophage-induced Breast Cancer Cell Epithelial-mesenchymal transition and Cancer Stem Cell formation.
Liu Q; Hodge J; Wang J; Wang Y; Wang L; Singh U; Li Y; Yao Y; Wang D; Ai W; Nagarkatti P; Chen H; Xu P; Murphy EA; Fan D
Theranostics; 2020; 10(18):8365-8381. PubMed ID: 32724475
[TBL] [Abstract][Full Text] [Related]
25. Stem cell state and the epithelial-to-mesenchymal transition: Implications for cancer therapy.
Donnenberg VS; Donnenberg AD
J Clin Pharmacol; 2015 Jun; 55(6):603-19. PubMed ID: 25708160
[TBL] [Abstract][Full Text] [Related]
26. Epithelial-mesenchymal transition (EMT): principles and clinical impact in cancer therapy.
Franco-Chuaire ML; Magda Carolina SC; Chuaire-Noack L
Invest Clin; 2013 Jun; 54(2):186-205. PubMed ID: 23947008
[TBL] [Abstract][Full Text] [Related]
27. Cancer stem cell targeting: the next generation of cancer therapy and molecular imaging.
Shigdar S; Lin J; Li Y; Yang CJ; Wei M; Zhus Y; Liu H; Duan W
Ther Deliv; 2012 Feb; 3(2):227-44. PubMed ID: 22834199
[TBL] [Abstract][Full Text] [Related]
28. EGFR inhibitors prevent induction of cancer stem-like cells in esophageal squamous cell carcinoma by suppressing epithelial-mesenchymal transition.
Sato F; Kubota Y; Natsuizaka M; Maehara O; Hatanaka Y; Marukawa K; Terashita K; Suda G; Ohnishi S; Shimizu Y; Komatsu Y; Ohashi S; Kagawa S; Kinugasa H; Whelan KA; Nakagawa H; Sakamoto N
Cancer Biol Ther; 2015; 16(6):933-40. PubMed ID: 25897987
[TBL] [Abstract][Full Text] [Related]
29. Targeting signal transduction pathways of cancer stem cells for therapeutic opportunities of metastasis.
Iqbal W; Alkarim S; AlHejin A; Mukhtar H; Saini KS
Oncotarget; 2016 Nov; 7(46):76337-76353. PubMed ID: 27486983
[TBL] [Abstract][Full Text] [Related]
30. Sonic hedgehog (Shh) signaling promotes tumorigenicity and stemness via activation of epithelial-to-mesenchymal transition (EMT) in bladder cancer.
Islam SS; Mokhtari RB; Noman AS; Uddin M; Rahman MZ; Azadi MA; Zlotta A; van der Kwast T; Yeger H; Farhat WA
Mol Carcinog; 2016 May; 55(5):537-51. PubMed ID: 25728352
[TBL] [Abstract][Full Text] [Related]
31. Novel cancer stem cell targets during epithelial to mesenchymal transition in PTEN-deficient trastuzumab-resistant breast cancer.
Sun L; Burnett J; Gasparyan M; Xu F; Jiang H; Lin CC; Myers I; Korkaya H; Liu Y; Connarn J; He H; Zhang N; Wicha MS; Sun D
Oncotarget; 2016 Aug; 7(32):51408-51422. PubMed ID: 27285982
[TBL] [Abstract][Full Text] [Related]
32. Biological role of metabolic reprogramming of cancer cells during epithelial‑mesenchymal transition (Review).
Li M; Bu X; Cai B; Liang P; Li K; Qu X; Shen L
Oncol Rep; 2019 Feb; 41(2):727-741. PubMed ID: 30483813
[TBL] [Abstract][Full Text] [Related]
33. Targeting cancer stem cells in cholangiocarcinoma (Review).
Mcgrath NA; Fu J; Gu SZ; Xie C
Int J Oncol; 2020 Aug; 57(2):397-408. PubMed ID: 32468022
[TBL] [Abstract][Full Text] [Related]
34. SHP-2-upregulated ZEB1 is important for PDGFRα-driven glioma epithelial-mesenchymal transition and invasion in mice and humans.
Zhang L; Zhang W; Li Y; Alvarez A; Li Z; Wang Y; Song L; Lv D; Nakano I; Hu B; Cheng SY; Feng H
Oncogene; 2016 Oct; 35(43):5641-5652. PubMed ID: 27041571
[TBL] [Abstract][Full Text] [Related]
35. The Role Played by SLUG, an Epithelial-Mesenchymal Transition Factor, in Invasion and Therapeutic Resistance of Malignant Glioma.
Oh SJ; Ahn EJ; Kim O; Kim D; Jung TY; Jung S; Lee JH; Kim KK; Kim H; Kim EH; Lee KH; Moon KS
Cell Mol Neurobiol; 2019 Aug; 39(6):769-782. PubMed ID: 31011939
[TBL] [Abstract][Full Text] [Related]
36. Targeting epithelial-mesenchymal transition phenotype for gastro-intestinal cancer.
Fan HC; Lin SZ; Harn HJ
Curr Pharm Des; 2015; 21(21):2942-55. PubMed ID: 26004417
[TBL] [Abstract][Full Text] [Related]
37. Deadly crosstalk: Notch signaling at the intersection of EMT and cancer stem cells.
Espinoza I; Miele L
Cancer Lett; 2013 Nov; 341(1):41-5. PubMed ID: 23973264
[TBL] [Abstract][Full Text] [Related]
38. Role of epithelial-mesenchymal transition in gastric cancer initiation and progression.
Peng Z; Wang CX; Fang EH; Wang GB; Tong Q
World J Gastroenterol; 2014 May; 20(18):5403-10. PubMed ID: 24833870
[TBL] [Abstract][Full Text] [Related]
39. Berberine induces neuronal differentiation through inhibition of cancer stemness and epithelial-mesenchymal transition in neuroblastoma cells.
Naveen CR; Gaikwad S; Agrawal-Rajput R
Phytomedicine; 2016 Jun; 23(7):736-44. PubMed ID: 27235712
[TBL] [Abstract][Full Text] [Related]
40. A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cells.
Jhaveri N; Agasse F; Armstrong D; Peng L; Commins D; Wang W; Rosenstein-Sisson R; Vaikari VP; Santiago SV; Santos T; Chen L; Schönthal AH; Chen TC; Hofman FM
Cancer Lett; 2016 Feb; 371(2):240-50. PubMed ID: 26683773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]